newsfilter
← Latest News
Business Wire·

Charles River, Labcorp, and FDA Collaborate to Validate New Preclinical Methods for Abuse Potential Assessment

Joint research effort seeks to improve abuse potential assessment tools to support drug development and public health decision-making Charles River Laboratories International, Inc. (NYSE:CRL) today announced a